ResMed
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,463,647 | $1,431,406 | $1,422,808 | $1,335,582 |
Gross Profit | 861,216 | 890,979 | 884,660 | 820,820 |
EBITDA | 492,964 | 583,631 | 566,426 | 503,284 |
EBIT | 474,164 | 514,599 | 504,096 | 455,586 |
Net Income | 383,432 | 398,732 | 392,593 | 348,536 |
Net Change In Cash | 1,463,647 | 1,431,406 | 1,422,808 | 1,335,582 |
Free Cash Flow | 1,649,544 | 520,478 | 305,190 | 414,356 |
Cash | 1,469,234 | 1,660,513 | 1,417,069 | 1,383,848 |
Basic Shares | 144,976 | 147,037 | 147,037 | 147,037 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $5,653,443 | $5,146,327 | $4,685,297 | $4,222,993 |
Gross Profit | 3,457,675 | 3,054,970 | 2,655,303 | 2,355,662 |
EBITDA | 2,146,305 | 1,913,377 | 1,533,543 | 1,358,801 |
EBIT | 1,948,445 | 1,677,566 | 1,317,334 | 1,162,279 |
Net Income | 1,523,293 | 1,400,723 | 1,020,951 | 897,556 |
Net Change In Cash | 5,653,443 | 5,146,327 | 4,685,297 | 4,222,993 |
Free Cash Flow | 1,649,544 | 1,661,723 | 1,286,404 | 559,299 |
Cash | 1,469,234 | 1,209,450 | 238,361 | 227,891 |
Basic Shares | 144,976 | 147,340 | 147,550 | 147,455 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $2.95 |
2026-03-31 | $2.86 |
2025-12-31 | $2.81 |
2025-09-30 | $2.55 |